Orphan designation: Bitopertin Treatment of erythropoietic protoporphyria, 15/02/2023 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 19 January 2024 - 13:54

Orphan designation: Bitopertin Treatment of erythropoietic protoporphyria, 15/02/2023 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-23-2761

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters